Hydroxyprogesterone Caproate

Hydroxyprogesterone Caproate is a synthetic progestogen and long-acting injectable analogue of progesterone used in luteal phase support to maintain uterine quiescence and support early pregnancy through sustained peripheral conversion to active metabolites.

206

Publications

9.5K

Citations

796

Authors

309

Institutions

Publications per year

2017–2026

26

Variants

17-Alpha-hydroxyprogesterone Caproate17-Ohpc

Authors

796

  1. SN
    Steve N. Caritis

    University of Pittsburgh, United States

    24 publications · 3.1K citations

    19

    h-index

  2. JD
    Jay D. Iams

    The Ohio State University, United States

    20 publications · 3.1K citations

    18

    h-index

  3. BM
    Brian M. Mercer

    Case Western Reserve University, United States

    18 publications · 2.9K citations

    17

    h-index

  4. MW
    Michael W. Varner

    University of Utah, United States

    17 publications · 2.7K citations

    16

    h-index

  5. SM
    Susan M. Ramin

    The University of Texas Southwestern Medical Center, United States

    15 publications · 2.7K citations

    15

    h-index

1–5 of 796

Venues

  1. American Journal of Obstetrics and Gynecology

    AJOG · 56 publications · 2.6K citations

    30

    h-index

  2. Obstetrics and Gynecology

    13 publications · 859 citations

    13

    h-index

  3. PubMed

    Repository · 16 publications · 613 citations

    13

    h-index

  4. Annals of the New York Academy of Sciences

    10 publications · 229 citations

    10

    h-index

  5. American Journal of Perinatology

    10 publications · 417 citations

    10

    h-index

1–5